Is catechol-o-methyltransferase gene polymorphism a risk factor in the development of premenstrual syndrome?.
10.5653/cerm.2014.41.2.62
- Author:
Esma Ozturk DEVECI
1
;
Adnan INCEBIYIK
;
Salih SELEK
;
Aysun CAMUZCUOGLU
;
Nese Gul HILALI
;
Hakan CAMUZCUOGLU
;
Mehmet Emin ERDAL
;
Mehmet VURAL
Author Information
1. Department of Gynecology and Obstetrics, Faculty of Medicine, Harran University, Sanliurfa, Turkey. dr.aincebiyik@gmail.com
- Publication Type:Original Article
- Keywords:
Catechol-o-methyltransferase;
Etiology;
Neurotransmitter;
Premenstrual syndrome
- MeSH:
Arthralgia;
Body Mass Index;
Catechol O-Methyltransferase*;
Child;
Female;
Gynecology;
Humans;
Menstrual Cycle;
Neurotransmitter Agents;
Obstetrics;
Parity;
Pregnancy;
Premenstrual Syndrome*;
Psychotic Disorders;
Risk Factors*
- From:Clinical and Experimental Reproductive Medicine
2014;41(2):62-67
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The objective of this study was to investigate whether there was a correlation between catechol-o-methyltransferase (COMT) gene polymorphism, which is believed to play a role in the etiology of psychotic disorders, and premenstrual syndrome (PMS). METHODS: Fifty-three women with regular menstrual cycles, aged between 18 and 46 years and diagnosed with PMS according to the American Congress of Obstetrics and Gynecology criteria were included in this study as the study group, and 53 healthy women having no health problems were selected as the controls. Venous blood was collected from all patients included in the study and kept at -18degrees C prior to analysis. RESULTS: There was no significant difference between the groups in terms of demographic features such as age, body mass index, number of pregnancies, parity, and number of children. No statistically significant difference was observed in terms of COMT gene polymorphism (p=0.61) between women in the PMS and the control groups. However, a significant difference was found between arthralgia, which is an indicator of PMS, and low-enzyme activity COMT gene (Met/Met) polymorphism (p=0.04). CONCLUSION: These results suggested that there was no significant relationship between PMS and COMT gene polymorphism. Since we could not find a direct correlation between the COMT gene polymorphism and PMS, further studies including alternative neurotransmitter pathways are needed to find an effective treatment for this disease.
